TARGET M0035466200Recalls & reported problems
Stryker Corporation · 360 Standard Detachable Coil · Class 2 · Implant
All models of TARGET (114)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 04546540676276), received between Mar 16, 2021 and Sep 2, 2025 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Fracture” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Fracture1
- Migration1
- Premature Separation1
Patient problems
- Foreign Body In Patient1
- No Clinical Signs, Symptoms or Conditions1
- Stroke/CVA1
- Vasoconstriction1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 2, 2025Premature Separation; Premature Separation
IT WAS REPORTED DURING THE PROCEDURE WHEN THE SUBJECT COIL WAS BEING DELIVERED INTO THE ANEURYSM, THE PHYSICIAN NEEDED TO ADJUST THE DELIVERY CONFIGURATION. UPON ADJUSTMENT, THE COIL PREMATURELY DETACHED HALF IN THE ANEURYSM AND HALF IN THE MCA VESSEL. THE PHYSICIAN USED TWO RETRIEVERS TO ATTEMPT TO RETRIEVE THE COIL BUT WAS UNSUCCESSFUL AND THE RETRIEVER FELL INTO THE ANEURYSM. THE PHYSICIAN ABANDONED THE PROCEDURE AFTER A 60 MINUTE DELAY. THE PATIENT WAS TRANSFERRED TO NEUROSURGERY FOR A FOR CLIPPING AND COIL REMOVAL. THE PATIENT HAD VASOSPASM DURING THE INTERVENTION AND SUFFERED MCA STROKE AFTERWARDS. NO OTHER INFORMATION IS AVAILABLE.
Patient problems: Foreign Body In Patient; Stroke/CVA; Vasoconstriction
MAUDE report 22940800 ↗MalfunctionMar 16, 2021Fracture; Migration; Fracture; Migration
IT WAS REPORTED THAT DURING THE PROCEDURE FOR LEFT ICA (INTERNAL CAROTID ARTERY) ANEURYSM CASE, PHYSICIAN USED MICROCATHETER TO INSERT SUBJECT COIL. WHEN INSERTING THE SUBJECT COIL, ITS WAS NOTED THAT THE PROXIMAL PORTION HAD STRETCHED DURING THE FRAMING IN ANEURYSM AND THAT THE CORE WIRE HAD FLOWED TO THE DISTAL PART OF THE VESSEL. THE PHYSICIAN TRIED TO WITHDRAW SUBJECT COIL, BUT THE PROXIMAL PORTION HAD FRACTURED AND WAS LEFT BEHIND UPON REMOVAL. A SNARE DEVICE WAS USED TO RETRIEVE THE FRACTURED FRAGMENT OF SUBJECT COIL AND ANOTHER COIL WAS USED TO CONTINUE THE PROCEDURE. THE PROCEDURE WAS COMPLETED SUCCESSFULLY AND NO CLINICAL CONSEQUENCES WERE NOTED TO THE PATIENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11499504 ↗
Other Device, Vascular, for Promoting Embolization devices
- POD RBYPOD8-APenumbra, Inc. · Device, Vascular, For Promoting Embolization195 reports
- CEREPAKTM MDH1Cerenovus, Inc. · Device, Vascular, for Promoting Embolization1 recall72 reports
- Azur CX Detachable 45-750824Microvention, Inc. · Device, Vascular, for Promoting Embolization115 reports
- Tornado G08261Cook Incorporated · Device, Vascular, for Promoting Embolization2 recalls7 reports
- Optima Coil System OPTI0930CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls4 reports
- Optima Coil System OPTI0720CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls4 reports
- Optima Coil System OPTI0413CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls3 reports
- Prestige Coil System PRES0520HPKPLBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls3 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page